| Field | Specification |
|---|---|
| Target | |
| Alternative names | Matrix metalloproteinase-9;MMP-9;3.4.24.35;92 kDa gelatinase;92 kDa type IV collagenase;Gelatinase B;GELB;67 kDa matrix metalloproteinase-9;82 kDa matrix metalloproteinase-9;MMP9;CLG4B; |
| UniProt # | |
| Host | |
| Clone | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | A synthesized peptide derived from human MMP9 |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Liquid |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Clone BCD-13 is a rabbit monoclonal antibody that recognizes matrix metalloproteinase-9 (gene MMP9) in human and rat samples and is validated for Western blot, IHC, ICC/IF and flow cytometry. The predicted molecular weight is 78.5 kDa, and the supplier reports an observed band at about 80–100 kDa.
MMP-9 (gelatinase B) is a secreted matrix metalloproteinase that degrades type IV and V collagens, gelatin and other matrix proteins. It supports leukocyte migration, tissue remodeling and osteoclast bone resorption, and it is widely measured in studies of inflammation, vascular disease, and tumor invasion.
| Target | Matrix metalloproteinase-9 (gene MMP9; UniProt P14780, human) |
|---|---|
| Clone | BCD-13 |
| Host / Clonality / Isotype | Rabbit / Monoclonal / Rabbit IgG |
| Reactivity | Human, Rat |
| Form | Liquid |
| Formulation | PBS (pH 7.4); 150 mM NaCl; 0.02% sodium azide; 50% glycerol; plus stabilizers |
| Calculated MW | 78.5 kDa |
| Observed MW | 80–100 kDa |
| Storage | Long term: −20 °C for up to 12 months. Frequent use: 4 °C for up to 1 month. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 1:500–1:2000 |
|---|---|
| Immunohistochemistry | 1:50–1:200 |
| Immunocytochemistry / Immunofluorescence | 1:50–1:200 |
| Flow cytometry | 1:50 |
Samples with a confirmed band (WB): rat kidney tissue, rat lung tissue.
Recommended loading (WB): 20–40 µg of total protein per lane.
Samples with confirmed staining (IHC): human spleen tissue, human tonsil tissue.
Recommended antigen retrieval: heat-mediated, in TE buffer (pH 9.0); citrate buffer (pH 6.0) can be used instead.
Conditions in the example images (IHC): heat-mediated antigen retrieval in EDTA buffer (pH 8.0).
Samples with confirmed staining (ICC/IF): U87-MG cells.
Immunogen
Synthetic peptide based on the sequence of human MMP9.
Reactivity Notes
The supplier lists reactivity with human and rat. Tissue expression noted by UniProt (human): Detected in neutrophils (at protein level). The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Xinxing Wang et al. (2026) Coptis chinensis extracellular vesicles loaded with CA1-siRNA promote endothelial repair and stent restenosis therapy by regulating the PADI2 and NF-κB pathway. Journal of Nanobiotechnology. 10.1186/s12951-026-04092-z
Chao Wang et al. (2025) tRF-AspGTC Promotes Intracranial Aneurysm Formation by Controlling TRIM29-Mediated Galectin-3 Ubiquitination. Research. 10.34133/research.0574
Hao Li et al. (2024) Somatic PDGFRB activating variants promote smooth muscle cell phenotype modulation in intracranial fusiform aneurysm. Journal of Biomedical Science. 10.1186/s12929-024-01040-7
Tongmeng Jiang et al. (2018) Untangling the response of bone tumor cells and bone forming cells to matrix stiffness and adhesion ligand density by means of hydrogels. Biomaterials. 10.1016/j.biomaterials.2018.10.015
Haiying Xu et al. (2023) Royal jelly acid suppresses hepatocellular carcinoma tumorigenicity by inhibiting H3 histone lactylation at H3K9la and H3K14la sites. Phytomedicine. 10.1016/j.phymed.2023.154940
Juliana A. Camargo et al. (2023) The Effect of Gene Editing by CRISPR-Cas9 of miR-21 and the Indirect Target MMP9 in Metastatic Prostate Cancer. International Journal of Molecular Sciences. 10.3390/ijms241914847
Muhan Chen et al. (2025) Efficacy assessment of glycyrrhetinic acid-modified liposomes loaded with doxorubicin hydrochloride and cucurbitine B for synergistic treatment of hepatocellular carcinoma. International Journal of Pharmaceutics. 10.1016/j.ijpharm.2025.125360
Xinyue Liu et al. (2025) Parishin E from ginger-processed Gastrodia elata Bl. alleviates rheumatoid arthritis by regulating histone 3 lactylation at H3K18la and H3K27la sites. Frontiers in Pharmacology. 10.3389/fphar.2025.1682504
Yeke Wu et al. (2024) A breakthrough in periodontitis treatment: Revealing the pharmacodynamic substances and mechanisms of Kouqiangjie formula. Journal of Ethnopharmacology. 10.1016/j.jep.2024.117738
Yuan Liu et al. (2025) Development of an Effective Drug Carrier for Targeted Therapy in Lung Adenocarcinoma Using ROS-responsive Micelles. Journal of Drug Targeting. 10.1080/1061186X.2025.2571547
